Britt Vitalone - McKesson Chief Financial Officer, Executive Vice President

MCK Stock  USD 562.78  7.29  1.28%   

President

Mr. Britt Vitalone was appointed Chief Financial Officer, Executive Vice President of the Company effective January 1, 2018. He is currently Senior Vice President and Chief Financial Officer of U.S. Pharmaceutical and McKesson Specialty Health, which includes responsibility for all daytoday financial and accounting operations including long range planning and financial oversight of new strategic initiatives. From 2012 to 2014, Mr. Vitalone served as the Companys Senior Vice President, Corporationrationrate Financial Planning and Analysis and Mergers Acquisitions Finance with responsibility for the Companys financial planning, cash flow forecasting, mergers an acquisitions and competitive analysis functions. From 2009 to 2012, he was Senior Vice President and Chief Financial Officer of the Companys MedicalSurgical business, having joined the Company in 2006 as Vice President, Finance of the same business. Prior to joining the Company, Mr. Vitalone held a variety of financial leadership positions with General Electric Financial Assurance, CarMax, Inc. and Bausch Lomb Inc since 2018.
Age 54
Tenure 6 years
Address 6555 State Highway 161, Irving, TX, United States, 75039
Phone972 446 4800
Webhttps://www.mckesson.com
Vitalone holds a BS degree in accounting from St. John Fisher College and is a certified public accountant.

Britt Vitalone Latest Insider Activity

Tracking and analyzing the buying and selling activities of Britt Vitalone against McKesson stock is an integral part of due diligence when investing in McKesson. Britt Vitalone insider activity provides valuable insight into whether McKesson is net buyers or sellers over its current business cycle. Note, McKesson insiders must abide by specific rules, including filing SEC forms every time they buy or sell McKesson'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

McKesson Management Efficiency

The company has Return on Asset of 0.0392 % which means that on every $100 spent on assets, it made $0.0392 of profit. This is way below average. McKesson's management efficiency ratios could be used to measure how well McKesson manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to rise to 0.27 this year, although the value of Return On Tangible Assets will most likely fall to 0.04. At this time, McKesson's Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 17.5 B this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 36.5 B.
McKesson has 7.39 B in debt with debt to equity (D/E) ratio of 6.61, demonstrating that the company may be unable to create cash to meet all of its financial commitments. McKesson has a current ratio of 0.94, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for McKesson to invest in growth at high rates of return.

Similar Executives

Showing other executives

PRESIDENT Age

Christopher LoweryOwens Minor
57
David WilsonCardinal Health
N/A
Brian RiceCardinal Health
57
Jonathan LeonOwens Minor
57
George HenriquesPatterson Companies
64
Paul GuggenheimPatterson Companies
64
Les KorshPatterson Companies
54
Timothy RoganPatterson Companies
52
Michael LowryOwens Minor
62
James CPAHenry Schein
70
John WrightPatterson Companies
N/A
Jorge SahliehCardinal Health
N/A
Michael PintekCardinal Health
55
Patricia EnglishCardinal Health
44
Shana NealOwens Minor
55
Michael EttingerHenry Schein
63
Andrew LongOwens Minor
59
Mark ZacurOwens Minor
57
Kevin PohlmanPatterson Companies
61
Patricia CPACardinal Health
44
Frederic PechEDAP TMS SA
55
McKesson Corporation provides healthcare services in the United States and internationally. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. Mckesson Corp operates under Medical Distribution classification in the United States and is traded on New York Stock Exchange. It employs 58000 people. McKesson (MCK) is traded on New York Stock Exchange in USA. It is located in 6555 State Highway 161, Irving, TX, United States, 75039 and employs 45,000 people. McKesson is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

McKesson Leadership Team

Elected by the shareholders, the McKesson's board of directors comprises two types of representatives: McKesson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of McKesson. The board's role is to monitor McKesson's management team and ensure that shareholders' interests are well served. McKesson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, McKesson's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lori Schechter, Executive Vice President Chief Compliance Officer, General Counsel
Holly Weiss, VP Relations
Pete Slone, Senior Affairs
W Dunbar, Independent Director
Bradley Lerman, Independent Director
LeAnn Smith, Executive Officer
Kenneth Washington, Independent Director
M Jacobs, Independent Director
Kirk Kaminsky, President Business
Edward Mueller, Independent Chairman of the Board
Nancy Avila, Chief VP
James Hinton, Director
Richard Carmona, Independent Director
Marie Knowles, Independent Director
N Coles, Independent Director
Linda Mantia, Independent Director
Nancy Flores, Executive Vice President, Chief Technology Officer, Chief Information Officer
Tracy Faber, Chief Human Resource Officer, Executive Vice President
Susan Salka, Independent Director
Kevin Emerson, Interim Senior Vice President Chief Accounting Officer, Controller
Tom Rodgers, Executive Vice President and Chief Strategy and Business Development Officer
Paul Smith, Senior Taxes
Donald Knauss, Independent Director
Maria Martinez, Independent Director
Michele JD, Executive Officer
Brad Lerman, Independent Director
Kathleen Thompson, Director
Rachel Rodriguez, Vice Relations
Michele Lau, Executive Officer
Britt Vitalone, Chief Financial Officer, Executive Vice President
Thomas MBA, Executive Officer
Britt CPA, Executive CFO
Napoleon Rutledge, Senior Vice President Chief Accounting Officer, Controller
Francisco Fraga, Chief VP
Brian Tyler, President, Chief Executive Officer, Chief Operating Officer, Director
MChristine Jacobs, Independent Director
Lori JD, Board Advisor
Dominic Caruso, Independent Director

McKesson Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is McKesson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether McKesson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if McKesson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Mckesson Stock. Highlighted below are key reports to facilitate an investment decision about Mckesson Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in McKesson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy McKesson Stock please use our How to buy in McKesson Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of McKesson. If investors know McKesson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about McKesson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.62)
Dividend Share
2.57
Earnings Share
19.1
Revenue Per Share
2.5 K
Quarterly Revenue Growth
0.213
The market value of McKesson is measured differently than its book value, which is the value of McKesson that is recorded on the company's balance sheet. Investors also form their own opinion of McKesson's value that differs from its market value or its book value, called intrinsic value, which is McKesson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because McKesson's market value can be influenced by many factors that don't directly affect McKesson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between McKesson's value and its price as these two are different measures arrived at by different means. Investors typically determine if McKesson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, McKesson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.